EMCURE.NS Overview

Company Profile

Related stocks

IPCALAB.NS • India

IPCA LABORATORIES LTD

1,915.4 INR

5.02B USD 1Y +43%

ABBOTINDIA.NS • India

ABBOTT INDIA LIMITED

26,000 INR

5.71B USD 1Y -14.5%

AJANTPHARM.NS • India

AJANTA PHARMA LIMITED

3,410.1 INR

4.4B USD 1Y +40.8%

GRANULES.NS • India

GRANULES INDIA LIMITED

815.25 INR

2.3B USD 1Y +48.5%

NEULANDLAB.BO • India

NEULAND LABORATORIES LTD.

20,879.85 INR

2.77B USD 1Y +35.8%

ERIS.NS • India

ERIS LIFESCIENCES LIMITED

1,170.7 INR

1.68B USD 1Y -27.8%

PPLPHARMA.NS • India

PIRAMAL PHARMA LIMITED

196.88 INR

2.7B USD 1Y -0.4%

ALIVUS.NS • India

ALIVUS LIFE SCIENCES LTD

1,326.3 INR

1.68B USD 1Y +45.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

35.4% p.a.

Max Drawdown (3Y)

-40.7%

Sharpe Ratio (3Y)

0.33

Beta Factor

-0.08

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.